In this issue:
Epstein-Barr virus seropositivity in patients with early MS
Safety of teriflunomide in pregnancy
MS patients have increased infection risk
Non-compliance with DMTs in patients with MS
Determinants of switchingtherapy in RRMS patients
CSF analysis of neurosarcoidosis
Age at MS onset affects disability progression
Disease activity outcomes after various natalizumab washout periods
The neurologist’s role in advanced MS according to patients and care providers
Late relapses have a decreasing impact on disability worsening in SPMS
Please login below to download this issue (PDF)